Clorox Co /De/ financial data

Symbol
CLX on NYSE
Location
The Clorox Company, 1221 Broadway, Oakland, CA
Fiscal year end
June 30
Latest financial report
10-Q - Q3 2025 - Nov 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 81.2 % -14.5%
Quick Ratio 29 % -20.6%
Debt-to-equity 7.46K % +82.2%
Return On Equity 340 % +183%
Return On Assets 14.3 % +129%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 122M shares -1.46%
Common Stock, Shares, Outstanding 122M shares -1.54%
Entity Public Float 19.9B USD +12.4%
Common Stock, Value, Issued 131M USD 0%
Weighted Average Number of Shares Outstanding, Basic 123M shares -0.94%
Weighted Average Number of Shares Outstanding, Diluted 123M shares -1.33%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.77B USD -9.35%
Research and Development Expense 118M USD -7.81%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.01B USD +84.6%
Income Tax Expense (Benefit) 205M USD +16.5%
Net Income (Loss) Attributable to Parent 791M USD +122%
Earnings Per Share, Basic 6 USD/shares +122%
Earnings Per Share, Diluted 6 USD/shares +121%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 166M USD -40.3%
Inventory, Net 577M USD -2.86%
Assets, Current 1.7B USD +7.55%
Property, Plant and Equipment, Net 1.25B USD +0.73%
Operating Lease, Right-of-Use Asset 318M USD -6.75%
Intangible Assets, Net (Excluding Goodwill) 566M USD -16.9%
Goodwill 1.23B USD -0.49%
Other Assets, Noncurrent 476M USD -9.16%
Assets 5.53B USD +0.56%
Accounts Payable, Current 838M USD -11.8%
Employee-related Liabilities, Current 179M USD -5.79%
Liabilities, Current 2.23B USD +41.5%
Deferred Income Tax Liabilities, Net 20M USD -13%
Operating Lease, Liability, Noncurrent 286M USD -9.21%
Other Liabilities, Noncurrent 365M USD -58.2%
Liabilities 5.39B USD +2.22%
Accumulated Other Comprehensive Income (Loss), Net of Tax -165M USD -12.2%
Retained Earnings (Accumulated Deficit) 200M USD +545%
Stockholders' Equity Attributable to Parent -22M USD -137%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 138M USD -38.4%
Liabilities and Equity 5.53B USD +0.56%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 93M USD -57.9%
Net Cash Provided by (Used in) Financing Activities -59M USD +75.1%
Net Cash Provided by (Used in) Investing Activities -34M USD -138%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 131M shares 0%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1M USD -101%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 169M USD -40.1%
Deferred Tax Assets, Valuation Allowance 166M USD +44.3%
Deferred Tax Assets, Gross 560M USD +9.59%
Operating Lease, Liability 392M USD -6.22%
Payments to Acquire Property, Plant, and Equipment 36M USD -7.69%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 773M USD +9.8%
Lessee, Operating Lease, Liability, to be Paid 432M USD -6.29%
Property, Plant and Equipment, Gross 4.18B USD +1.02%
Operating Lease, Liability, Current 89M USD +7.23%
Lessee, Operating Lease, Liability, to be Paid, Year Two 94M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 101M USD +4.12%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +27.8%
Deferred Income Tax Expense (Benefit) 84M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 40M USD -6.98%
Lessee, Operating Lease, Liability, to be Paid, Year Three 82M USD -2.38%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 27M USD +22.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 68M USD -1.45%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 7M USD -12.5%
Depreciation, Depletion and Amortization 56M USD +3.7%
Deferred Tax Assets, Net of Valuation Allowance 394M USD -0.51%
Interest Expense 90M USD 0%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%